LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

Начало・Списък с акции・Lisata Therapeutics

L
Lisata Therapeutics

Затворен

5.02

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

4.99

Максимум

5.03

Ключови измерители
By Trading Economics
Приходи	410K -4.2M
Марж на печалбата	-6,655.714
Служители	26

Дивиденти
By Dow Jones
Следващи печалби	12.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	18M 38M
Предишно отваряне	5.02
Предишно затваряне	5.02

Lisata Therapeutics Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

11.03.2026 г., 19:18 ч. UTC

Значими двигатели на пазара

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

11.03.2026 г., 23:54 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

11.03.2026 г., 23:54 ч. UTC

Пазарно говорене

Nikkei May Decline on Energy Costs Concerns -- Market Talk

11.03.2026 г., 23:51 ч. UTC

Пазарно говорене

Gold Falls as Rising Oil Prices Spur Inflation Worries -- Market Talk

11.03.2026 г., 23:41 ч. UTC

Пазарно говорене

REA Bull Sees Potential Upside to Yield Guidance -- Market Talk

11.03.2026 г., 23:37 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Futures Rise Amid Ongoing Middle East Conflict -- Market Talk

11.03.2026 г., 23:17 ч. UTC

Значими събития в новините

Front-Month WTI Crude Oil Futures Rise 5.5% to $92.05/bbl

11.03.2026 г., 23:17 ч. UTC

Значими събития в новините

Front-Month Crude Oil Futures Rise Amid Ongoing Middle East Conflict

11.03.2026 г., 22:29 ч. UTC

Пазарно говорене

Australia Shares Set to Fall in Early Trade -- Market Talk

11.03.2026 г., 21:47 ч. UTC

Печалби

Liontown Resources: Market Tailwinds Strengthening Outlook

11.03.2026 г., 21:46 ч. UTC

Печалби

Liontown Resources: 4 Mln Ton Per Annum Expansion Study Underway

11.03.2026 г., 21:45 ч. UTC

Печалби

Liontown Resources Says FY26 Guidance Unchanged

11.03.2026 г., 21:45 ч. UTC

Печалби

Liontown Resources 1H Unit Operating Costs A$985/Ton

11.03.2026 г., 21:44 ч. UTC

Печалби

Liontown Resources 1H Underlying Ebitda Loss A$7.7 Million

11.03.2026 г., 21:43 ч. UTC

Печалби

Liontown Resources 1H Revenue A$207.5 Million

11.03.2026 г., 21:43 ч. UTC

Печалби

Liontown Resources 1H Net Loss A$184 Million

11.03.2026 г., 21:12 ч. UTC

Придобивния, сливания и поглъщания

Netflix Rival Strikes Deal With Google in Battle for AI Content -- Barrons.com

11.03.2026 г., 21:10 ч. UTC

Печалби

Vista Gold FY25 Loss $7.5M >VGZ

11.03.2026 г., 21:10 ч. UTC

Печалби

Vista Gold FY25 Loss/Shr 6c >VGZ

11.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Значими събития в новините

Basic Materials Roundup: Market Talk

11.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

11.03.2026 г., 20:27 ч. UTC

Придобивния, сливания и поглъщания

Papa John's Draws Fresh Takeover Interest -- 2nd Update

11.03.2026 г., 20:26 ч. UTC

Печалби

These Stocks Are Today's Movers: Oracle, UniFirst, Fair Isaac, Nebius, AeroVironment, Campbell's, and More -- Barrons.com

11.03.2026 г., 20:19 ч. UTC

Значими събития в новините

The Strait of Hormuz Could Take Weeks -- Even Months -- to Reopen, Military Experts Say -- Barrons.com

11.03.2026 г., 20:15 ч. UTC

Печалби

This Physical AI Stock Jumped on Earnings. The Robots Are Coming. -- Barrons.com

11.03.2026 г., 20:12 ч. UTC

Значими събития в новините

Stock Market Today: Oil Prices Push Higher Despite IEA Oil Release Headline -- WSJ

11.03.2026 г., 19:31 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Futures Gain Despite IEA's Planned Release of Reserves -- Market Talk

11.03.2026 г., 19:01 ч. UTC

Пазарно говорене

Значими събития в новините

U.S. Natural Gas Gains With Middle East Conflict in View -- Market Talk

11.03.2026 г., 18:59 ч. UTC

Придобивния, сливания и поглъщания

Berkshire's Deal for Occidental Chemicals Unit Is a Winner as Chemical Stocks Surge -- Barrons.com

11.03.2026 г., 18:43 ч. UTC

Значими събития в новините

Chubb Named Lead Insurer for U.S. Plan to Protect Oil Tankers in Strait of Hormuz -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Lisata Therapeutics Прогноза

Консенсусна оценка

By TipRanks

Неутрален

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Lisata Therapeutics през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Печалба преди облагане с данъци

Продажби

Оперативна печалба

Относно Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.